PHARMACYCLICS INC's ticker is PCYC and the CUSIP is 716933106. A total of 1 filers reported holding PHARMACYCLICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $6,832,000 | +102.9% | 26,691 | -3.1% | 0.01% | +125.0% |
| Q4 2014 | $3,368,000 | -1.0% | 27,548 | -4.9% | 0.00% | -20.0% |
| Q3 2014 | $3,402,000 | +28.0% | 28,967 | -2.2% | 0.01% | +25.0% |
| Q2 2014 | $2,657,000 | -5.0% | 29,614 | +6.1% | 0.00% | 0.0% |
| Q1 2014 | $2,798,000 | +5.0% | 27,917 | +10.8% | 0.00% | 0.0% |
| Q4 2013 | $2,665,000 | -5.7% | 25,191 | +23.2% | 0.00% | -20.0% |
| Q3 2013 | $2,826,000 | +78.5% | 20,441 | +2.6% | 0.01% | +66.7% |
| Q2 2013 | $1,583,000 | – | 19,916 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 9,129,231 | $1,116,140,000 | 11.39% |
| DAFNA Capital Management LLC | 110,928 | $13,562,000 | 10.73% |
| HWG Holdings LP | 107,389 | $13,129,000 | 9.36% |
| Opaleye Management Inc. | 85,000 | $10,392,000 | 5.25% |
| Opus Point Partners Management, LLC | 25,723 | $3,145,000 | 3.11% |
| BB BIOTECH AG | 731,542 | $89,438,000 | 2.90% |
| Peregrine Asset Advisers, Inc. | 33,375 | $4,080,000 | 2.87% |
| HARVEY CAPITAL MANAGEMENT INC | 54,770 | $6,696,000 | 2.57% |
| Parametric Risk Advisors LLC | 300,000 | $36,678,000 | 2.45% |
| BENDER ROBERT & ASSOCIATES | 28,619 | $3,499,000 | 2.29% |